ARTICLE | Clinical News
Ponatinib: Phase II started
September 20, 2010 7:00 AM UTC
Ariad began the single-arm, international, pivotal Phase II PACE trial to evaluate 45 mg oral ponatinib given once daily in 320 patients. The trial will include 80 patients each with accelerated phase...